397 related articles for article (PubMed ID: 25731953)
1. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
[TBL] [Abstract][Full Text] [Related]
2. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.
Dimitrakopoulou VI; Travis RC; Shui IM; Mondul A; Albanes D; Virtamo J; Agudo A; Boeing H; Bueno-de-Mesquita HB; Gunter MJ; Johansson M; Khaw KT; Overvad K; Palli D; Trichopoulou A; Giovannucci E; Hunter DJ; Lindström S; Willett W; Gaziano JM; Stampfer M; Berg C; Berndt SI; Black A; Hoover RN; Kraft P; Key TJ; Tsilidis KK
Am J Epidemiol; 2017 Mar; 185(6):452-464. PubMed ID: 28399564
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
4. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.
Torkko K; Till C; Tangen CM; Goodman PJ; Song X; Schenk JM; Lucia MS; Peters U; van Bokhoven A; Thompson IM; Neuhouser ML
Cancer Prev Res (Phila); 2020 Jun; 13(6):521-530. PubMed ID: 32102946
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
Clendenen TV; Ge W; Koenig KL; Axelsson T; Liu M; Afanasyeva Y; Andersson A; Arslan AA; Chen Y; Hallmans G; Lenner P; Kirchhoff T; Lundin E; Shore RE; Sund M; Zeleniuch-Jacquotte A
PLoS One; 2015; 10(10):e0140478. PubMed ID: 26488576
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).
Mondul AM; Shui IM; Yu K; Weinstein SJ; Tsilidis KK; Joshi AD; Agudo A; Berg CD; Black A; Buring JE; Chasman DI; Gaudet MM; Haiman C; Hankinson SE; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kühn T; Kvaskoff M; Le Marchand L; Lindström S; McCullough ML; Overvad K; Peeters PH; Riboli E; Ridker PM; Stram DO; Sund M; Trichopoulos D; Tumino R; Weiderpass E; Willett W; Kraft P; Ziegler RG; Albanes D
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):627-30. PubMed ID: 25542828
[TBL] [Abstract][Full Text] [Related]
13. Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations.
O'Brien KM; Sandler DP; Kinyamu HK; Taylor JA; Weinberg CR
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1761-1771. PubMed ID: 28830874
[No Abstract] [Full Text] [Related]
14. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer.
Hiraki LT; Qu C; Hutter CM; Baron JA; Berndt SI; Bézieau S; Brenner H; Caan BJ; Casey G; Chang-Claude J; Chanock SJ; Conti DV; Duggan D; Fuchs CS; Gallinger S; Giovannucci EL; Harrison TA; Hayes RB; Hazra A; Henderson B; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Küry S; Le Marchand L; Lemire M; Ma J; Manson JE; Nan H; Newcomb PA; Ng K; Potter JD; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Wactawski-Wende J; White E; Wu K; Zanke BW; Kraft P; Peters U; Chan AT
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2037-46. PubMed ID: 23983240
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-Related Genes, Blood Vitamin D Levels and Colorectal Cancer Risk in Western European Populations.
Fedirko V; Mandle HB; Zhu W; Hughes DJ; Siddiq A; Ferrari P; Romieu I; Riboli E; Bueno-de-Mesquita B; van Duijnhoven FJB; Siersema PD; Tjønneland A; Olsen A; Perduca V; Carbonnel F; Boutron-Ruault MC; Kühn T; Johnson T; Krasimira A; Trichopoulou A; Makrythanasis P; Thanos D; Panico S; Krogh V; Sacerdote C; Skeie G; Weiderpass E; Colorado-Yohar S; Sala N; Barricarte A; Sanchez MJ; Quirós R; Amiano P; Gylling B; Harlid S; Perez-Cornago A; Heath AK; Tsilidis KK; Aune D; Freisling H; Murphy N; Gunter MJ; Jenab M
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31434255
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
Barry EL; Rees JR; Peacock JL; Mott LA; Amos CI; Bostick RM; Figueiredo JC; Ahnen DJ; Bresalier RS; Burke CA; Baron JA
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2133-7. PubMed ID: 25070320
[TBL] [Abstract][Full Text] [Related]
18. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
19. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolic pathway genes and pancreatic cancer risk.
Arem H; Yu K; Xiong X; Moy K; Freedman ND; Mayne ST; Albanes D; Arslan AA; Austin M; Bamlet WR; Beane-Freeman L; Bracci P; Canzian F; Cotterchio M; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman PJ; Hartge P; Hassan M; Helzlsouer K; Henderson B; Holly EA; Hoover R; Jacobs EJ; Kamineni A; Klein A; Klein E; Kolonel LN; Li D; Malats N; Männistö S; McCullough ML; Olson SH; Orlow I; Peters U; Petersen GM; Porta M; Severi G; Shu XO; Visvanathan K; White E; Yu H; Zeleniuch-Jacquotte A; Zheng W; Tobias GS; Maeder D; Brotzman M; Risch H; Sampson JN; Stolzenberg-Solomon RZ
PLoS One; 2015; 10(3):e0117574. PubMed ID: 25799011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
